Division of Urology, St Joseph's Health Care, London, ON, Canada Department of Urology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
J Sex Med. 2013 Nov;10(11):2855-60. doi: 10.1111/jsm.12009. Epub 2012 Dec 4.
The implantation of inflatable penile prosthesis (IPP) with simultaneous manual penile remodeling allows for men to undergo a single procedure aimed at correcting both the penile deformity/curvature and erectile dysfunction (ED).
To evaluate the clinical outcomes and patient satisfaction in men with Peyronie's disease (PD) and ED who underwent AMS 700™ CX and the newer Coloplast™ Titan inflatable penile prosthesis (IPP) implant.
Patient demographics, type of IPP, clinical outcomes, post-implant sexual characteristics, and overall patient satisfaction.
A single-center retrospective review of clinical database and prospective telephone survey were conducted in all men with PD who underwent IPP between January 2006 and November 2010.
A total of 138 patients with an average age of 57.7 (32 to 80) underwent AMS 700 CX (88 patients) and Coloplast Titans (50 patients) IPP implantation during the 5-year period. The majority of patients (91%) had only one IPP implantation. The IPP clinical outcomes include eight (6%) revision surgery for device malfunction and three (2%) device explantation for prosthesis infection. While there was no statistically significance in device survival between the two devices, the trend favored AMS 700 CX over Titan (5-year Kaplan-Meier estimates of mechanical survival were 91% vs. 87%, P>0.05) and both IPPs provided similar penile straightening without the need for revision surgery. Most men (79%) reported great satisfaction following CX or Titan implants with greater than two thirds of men reported greater self-confidence and 82% of patients would undergo the same operation again.
AMS 700™ CX and Coloplast™ Titan IPP implantation and penile remodeling appeared to provide permanent penile straightening and high patient satisfaction without an increase risk of revision surgery.
植入可充气阴茎假体 (IPP) 并同时进行手动阴茎重塑，可让男性接受单一手术，以矫正阴茎畸形/弯曲和勃起功能障碍 (ED)。
评估同时患有 Peyronie 病 (PD) 和 ED 的男性接受 AMS 700™ CX 和较新型 Coloplast™ Titan 可充气阴茎假体 (IPP) 植入后的临床结果和患者满意度。
患者人口统计学资料、IPP 类型、临床结果、植入后的性特征和总体患者满意度。
对 2006 年 1 月至 2010 年 11 月期间在单一中心接受 IPP 治疗的所有 PD 男性患者进行了临床数据库的回顾性分析和前瞻性电话调查。
在 5 年期间，共有 138 名平均年龄为 57.7（32 至 80）岁的男性患者接受了 AMS 700 CX（88 名患者）和 Coloplast Titans（50 名患者）IPP 植入。大多数患者（91%）仅接受了一次 IPP 植入。IPP 临床结果包括 8 例（6%）因器械故障进行的翻修手术和 3 例（2%）因假体感染进行的器械取出。虽然两种设备的器械存活率无统计学差异，但趋势倾向于 AMS 700 CX 优于 Titan（5 年 Kaplan-Meier 机械存活率估计值分别为 91%和 87%，P>0.05），并且两种 IPP 均提供了类似的阴茎伸直效果，无需进行翻修手术。大多数男性（79%）在接受 CX 或 Titan 植入后报告非常满意，超过三分之二的男性报告自我信心增强，82%的患者会再次接受相同的手术。
AMS 700™ CX 和 Coloplast™ Titan IPP 植入和阴茎重塑似乎提供了永久性的阴茎伸直和高患者满意度，而不会增加翻修手术的风险。
